Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Furuta

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Journal of Neuropathology and Experimental Neurology|July 11, 2020
The Multipotential of Leucine-Rich α-2 Glycoprotein 1 as a Clinicopathological Biomarker of GlioblastomaTakuya Furuta, Yasuo Sugita, Satoru Komaki, et al.
Journal of the Anus, Rectum and Colon|August 4, 2020
Mesenteric Myxofibrosarcoma: A Case ReportKunihiro Ozaki, Fumihiko Fujita, Fumiki Koga, et al.
Journal of Neuro-Oncology|March 8, 2014
Prognostic paradox: brain damage around the glioblastoma resection cavityTakuya Furuta, Mitsutoshi Nakada, Fumiaki Ueda, et al.
Journal of Neuro-Oncology|November 26, 2009
The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patientsYuya Yoshida, Mitsutoshi Nakada, Tomoya Harada, et al.
Current Pharmaceutical Design|April 30, 2020
Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against GlioblastomaShabierjiang Jiapaer, Takuya Furuta, Yu Dong, et al.
Plos One|March 8, 2018
Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomicsEisuke Miyauchi, Takuya Furuta, Sumio Ohtsuki, et al.
Frontiers in Oncology|January 4, 2024
Case report: A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer: pitfall in managing immune-related adverse eventsToshimitsu Tanaka, Sachiko Nagasu, Takuya Furuta, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|October 26, 2017
The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1Yasuo Sugita, Takuya Furuta, Koichi Ohshima, et al.
Fundamental & Clinical Pharmacology|May 24, 2016
Amorphous nanosilica particles evoke vascular relaxation through PI3K/Akt/eNOS signalingAkira Onodera, Katsutoshi Yayama, Atsushi Tanaka, et al.
Hematological Oncology|June 23, 2020
Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T-cell leukemia/lymphomaEriko Yanagida, Hiroaki Miyoshi, Mai Takeuchi, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Journal of Neuropathology and Experimental Neurology|July 11, 2020
The Multipotential of Leucine-Rich α-2 Glycoprotein 1 as a Clinicopathological Biomarker of GlioblastomaTakuya Furuta, Yasuo Sugita, Satoru Komaki, et al.
Journal of the Anus, Rectum and Colon|August 4, 2020
Mesenteric Myxofibrosarcoma: A Case ReportKunihiro Ozaki, Fumihiko Fujita, Fumiki Koga, et al.
Journal of Neuro-Oncology|March 8, 2014
Prognostic paradox: brain damage around the glioblastoma resection cavityTakuya Furuta, Mitsutoshi Nakada, Fumiaki Ueda, et al.
Journal of Neuro-Oncology|November 26, 2009
The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patientsYuya Yoshida, Mitsutoshi Nakada, Tomoya Harada, et al.
Current Pharmaceutical Design|April 30, 2020
Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against GlioblastomaShabierjiang Jiapaer, Takuya Furuta, Yu Dong, et al.
Plos One|March 8, 2018
Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomicsEisuke Miyauchi, Takuya Furuta, Sumio Ohtsuki, et al.
Frontiers in Oncology|January 4, 2024
Case report: A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer: pitfall in managing immune-related adverse eventsToshimitsu Tanaka, Sachiko Nagasu, Takuya Furuta, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|October 26, 2017
The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1Yasuo Sugita, Takuya Furuta, Koichi Ohshima, et al.
Fundamental & Clinical Pharmacology|May 24, 2016
Amorphous nanosilica particles evoke vascular relaxation through PI3K/Akt/eNOS signalingAkira Onodera, Katsutoshi Yayama, Atsushi Tanaka, et al.
Hematological Oncology|June 23, 2020
Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T-cell leukemia/lymphomaEriko Yanagida, Hiroaki Miyoshi, Mai Takeuchi, et al.
Pageof 12